Induction of oxidative stress by anticancer drugs in the presence and absence of cells

Chikako Yokoyama, Yuto Sueyoshi, Mika Ema, Yumi Mori, Kazuto Takaishi, Hisashi Hisatomi

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Reactive oxygen species (ROS) are generated in the cell through multiple mechanisms. Intracellular ROS are rapidly detoxified by various enzymatic and non-enzymatic mechanisms; however, disruption of the oxidant-antioxidant balance causes oxidative stress and elicits cell damage. The oxidative stress induced by chemotherapy is known to cause side effects in patients with cancer. However, few studies have examined whether anticancer drugs induce oxidative stress in cancer cells. Furthermore, the precise mechanism by which anticancer drugs induce the generation of ROS remains unclear. In the present study, to investigate whether anticancer drugs induce oxidative stress, DLD-1 human colorectal cancer cells were treated with 20 different anticancer drugs and then stained with CellROX® ROS detection reagent. Furthermore, an oxygen radical absorbance capacity assay in the presence of copper was performed to estimate the oxidative activities of the anticancer drugs in the absence of cells. The data of the present study using assay methods in the presence and absence of cells suggest that nimustine, actinomycin D, doxorubicin, mitomycin C, mitoxantrone, carmofur, gemcitabine, mercaptopurine, camptothecin, paclitaxel, vinblastine, and vinorelbine are able to induce oxidative stress.

Original languageEnglish
Pages (from-to)6066-6070
Number of pages5
JournalOncology Letters
Volume14
Issue number5
DOIs
Publication statusPublished - Nov 1 2017

Fingerprint

Oxidative Stress
Reactive Oxygen Species
Pharmaceutical Preparations
gemcitabine
Nimustine
6-Mercaptopurine
Camptothecin
Mitoxantrone
Vinblastine
Dactinomycin
Mitomycin
Paclitaxel
Oxidants
Doxorubicin
Copper
Colorectal Neoplasms
Neoplasms
Antioxidants
Drug Therapy

Keywords

  • Anticancer drug
  • CellROX®
  • Oxidative stress
  • Reactive oxygen species
  • The oxygen radical absorbance capacity assay in the presence of copper

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Induction of oxidative stress by anticancer drugs in the presence and absence of cells. / Yokoyama, Chikako; Sueyoshi, Yuto; Ema, Mika; Mori, Yumi; Takaishi, Kazuto; Hisatomi, Hisashi.

In: Oncology Letters, Vol. 14, No. 5, 01.11.2017, p. 6066-6070.

Research output: Contribution to journalArticle

Yokoyama, Chikako ; Sueyoshi, Yuto ; Ema, Mika ; Mori, Yumi ; Takaishi, Kazuto ; Hisatomi, Hisashi. / Induction of oxidative stress by anticancer drugs in the presence and absence of cells. In: Oncology Letters. 2017 ; Vol. 14, No. 5. pp. 6066-6070.
@article{661f6b895bdc486184821d5d706e63fb,
title = "Induction of oxidative stress by anticancer drugs in the presence and absence of cells",
abstract = "Reactive oxygen species (ROS) are generated in the cell through multiple mechanisms. Intracellular ROS are rapidly detoxified by various enzymatic and non-enzymatic mechanisms; however, disruption of the oxidant-antioxidant balance causes oxidative stress and elicits cell damage. The oxidative stress induced by chemotherapy is known to cause side effects in patients with cancer. However, few studies have examined whether anticancer drugs induce oxidative stress in cancer cells. Furthermore, the precise mechanism by which anticancer drugs induce the generation of ROS remains unclear. In the present study, to investigate whether anticancer drugs induce oxidative stress, DLD-1 human colorectal cancer cells were treated with 20 different anticancer drugs and then stained with CellROX{\circledR} ROS detection reagent. Furthermore, an oxygen radical absorbance capacity assay in the presence of copper was performed to estimate the oxidative activities of the anticancer drugs in the absence of cells. The data of the present study using assay methods in the presence and absence of cells suggest that nimustine, actinomycin D, doxorubicin, mitomycin C, mitoxantrone, carmofur, gemcitabine, mercaptopurine, camptothecin, paclitaxel, vinblastine, and vinorelbine are able to induce oxidative stress.",
keywords = "Anticancer drug, CellROX{\circledR}, Oxidative stress, Reactive oxygen species, The oxygen radical absorbance capacity assay in the presence of copper",
author = "Chikako Yokoyama and Yuto Sueyoshi and Mika Ema and Yumi Mori and Kazuto Takaishi and Hisashi Hisatomi",
year = "2017",
month = "11",
day = "1",
doi = "10.3892/ol.2017.6931",
language = "English",
volume = "14",
pages = "6066--6070",
journal = "Oncology Letters",
issn = "1792-1074",
publisher = "Spandidos Publications",
number = "5",

}

TY - JOUR

T1 - Induction of oxidative stress by anticancer drugs in the presence and absence of cells

AU - Yokoyama, Chikako

AU - Sueyoshi, Yuto

AU - Ema, Mika

AU - Mori, Yumi

AU - Takaishi, Kazuto

AU - Hisatomi, Hisashi

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Reactive oxygen species (ROS) are generated in the cell through multiple mechanisms. Intracellular ROS are rapidly detoxified by various enzymatic and non-enzymatic mechanisms; however, disruption of the oxidant-antioxidant balance causes oxidative stress and elicits cell damage. The oxidative stress induced by chemotherapy is known to cause side effects in patients with cancer. However, few studies have examined whether anticancer drugs induce oxidative stress in cancer cells. Furthermore, the precise mechanism by which anticancer drugs induce the generation of ROS remains unclear. In the present study, to investigate whether anticancer drugs induce oxidative stress, DLD-1 human colorectal cancer cells were treated with 20 different anticancer drugs and then stained with CellROX® ROS detection reagent. Furthermore, an oxygen radical absorbance capacity assay in the presence of copper was performed to estimate the oxidative activities of the anticancer drugs in the absence of cells. The data of the present study using assay methods in the presence and absence of cells suggest that nimustine, actinomycin D, doxorubicin, mitomycin C, mitoxantrone, carmofur, gemcitabine, mercaptopurine, camptothecin, paclitaxel, vinblastine, and vinorelbine are able to induce oxidative stress.

AB - Reactive oxygen species (ROS) are generated in the cell through multiple mechanisms. Intracellular ROS are rapidly detoxified by various enzymatic and non-enzymatic mechanisms; however, disruption of the oxidant-antioxidant balance causes oxidative stress and elicits cell damage. The oxidative stress induced by chemotherapy is known to cause side effects in patients with cancer. However, few studies have examined whether anticancer drugs induce oxidative stress in cancer cells. Furthermore, the precise mechanism by which anticancer drugs induce the generation of ROS remains unclear. In the present study, to investigate whether anticancer drugs induce oxidative stress, DLD-1 human colorectal cancer cells were treated with 20 different anticancer drugs and then stained with CellROX® ROS detection reagent. Furthermore, an oxygen radical absorbance capacity assay in the presence of copper was performed to estimate the oxidative activities of the anticancer drugs in the absence of cells. The data of the present study using assay methods in the presence and absence of cells suggest that nimustine, actinomycin D, doxorubicin, mitomycin C, mitoxantrone, carmofur, gemcitabine, mercaptopurine, camptothecin, paclitaxel, vinblastine, and vinorelbine are able to induce oxidative stress.

KW - Anticancer drug

KW - CellROX®

KW - Oxidative stress

KW - Reactive oxygen species

KW - The oxygen radical absorbance capacity assay in the presence of copper

UR - http://www.scopus.com/inward/record.url?scp=85030166215&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030166215&partnerID=8YFLogxK

U2 - 10.3892/ol.2017.6931

DO - 10.3892/ol.2017.6931

M3 - Article

AN - SCOPUS:85030166215

VL - 14

SP - 6066

EP - 6070

JO - Oncology Letters

JF - Oncology Letters

SN - 1792-1074

IS - 5

ER -